Pathogenesis of Pediatric Nonalcoholic Fatty Liver Disease (NAFLD)
NCT04634643 · Status: RECRUITING · Type: OBSERVATIONAL · Enrollment: 260
Last updated 2025-01-27
Summary
The main aim of the study is to discover the mechanisms underlying the pathophysiology of NAFLD in obese youth.
Conditions
- NAFLD
Interventions
- OTHER
-
Usual diet and physical activity
Patients will be followed up to assess the effect of the usual diet and physical activity on development of NAFLD
Sponsors & Collaborators
-
National Institute on Minority Health and Health Disparities (NIMHD)
collaborator NIH -
Yale University
lead OTHER
Principal Investigators
-
Nicola Santoro, MD, PhD · Associate Professor of Pediatrics (Endocrinology)
Eligibility
- Min Age
- 12 Years
- Max Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2021-06-28
- Primary Completion
- 2026-01-30
- Completion
- 2026-01-30
Countries
- United States
Study Locations
More Related Trials
-
A Carbohydrate-restricted Diet to Reverse Fatty Liver in Adolescents With Obesity
NCT02787668 ·Status: COMPLETED ·Phase: NA
-
Curcumin for Pediatric Nonalcoholic Fatty Liver Disease
NCT04109742 ·Status: WITHDRAWN ·Phase: PHASE2
-
Fructose and Liver Diseases in Youth: Help Them FLY
NCT05528471 ·Status: RECRUITING ·Phase: NA
-
Effects of Tomato Products in Children With NAFLD
NCT03463967 ·Status: UNKNOWN ·Phase: NA
-
Healthy Eating Through Reduction Of Excess Sugar
NCT02948647 ·Status: COMPLETED ·Phase: NA
-
Effect of VLCD on the Reduction of Liver Steatosis and Fibrosis in Subjects With Obesity and NAFLD
NCT04861571 ·Status: ACTIVE_NOT_RECRUITING ·Phase: NA
-
Hepatoprotective Measures for Children at High Risk of NAFLD
NCT06918080 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE4
-
Effects of Docosahexaenoic Acid (DHA) on Children With Nonalcoholic Fatty Liver Disease (NAFLD)
NCT00885313 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
Gemcabene for the Treatment of Pediatric NAFLD
NCT03436420 ·Status: TERMINATED ·Phase: PHASE2
-
Phase I Study of Colchicine Therapy in Childhood Hepatic Cirrhosis
NCT00004368 ·Status: UNKNOWN ·Phase: PHASE1
-
Evaluation of Intestinal Microbiome in Obese Kids
NCT00816296 ·Status: WITHDRAWN
-
Treating Pediatric NAFLD with Nutrition
NCT05499585 ·Status: COMPLETED ·Phase: NA
-
Efficacy of Phosphatidylcholine in NAFLD
NCT04411862 ·Status: COMPLETED ·Phase: PHASE3
-
Effect of Bile Acids on Satiety, Cell Function and Body Weight in Patients With Obesity and Abnormal Satiety Phenotype
NCT05314374 ·Status: COMPLETED ·Phase: PHASE1
-
Dietary Treatment Study of Pediatric NAFLD
NCT02513121 ·Status: COMPLETED ·Phase: NA
-
Stimulating Fat Tissue Storage With Niacin to Reduce Fat Accumulation in the Liver.
NCT06843148 ·Status: RECRUITING ·Phase: NA
-
Evaluating the Metabolic Effects of Polylactose: A Novel Prebiotic
NCT04100109 ·Status: WITHDRAWN ·Phase: NA
-
Standard Lipid Therapy vs IVFE Minimization for Prevention of PNALD
NCT02357576 ·Status: COMPLETED ·Phase: PHASE3
-
Effect of Vitamin E on Pediatric Nonalcoholic Fatty Liver Disease (NAFLD)
NCT00655018 ·Status: COMPLETED ·Phase: PHASE2/PHASE3
-
Effect of Polyphenol Supplementation on Hepatic Steatosis and Vascular Compliance
NCT03994029 ·Status: RECRUITING ·Phase: NA
-
Efficacy and Tolerance of Treatment With DHA, Choline and Vitamin E in Children With Non-alcoholic Steatohepatitis
NCT01934777 ·Status: COMPLETED ·Phase: PHASE3
-
Study of the Safety and Tolerability of AXA1957 in Adolescent Subjects With Non-Alcoholic Fatty Liver Disease (NAFLD)
NCT04073407 ·Status: TERMINATED ·Phase: NA
-
Study of Lactulose in Children With Chronic Liver Disease
NCT00811434 ·Status: TERMINATED ·Phase: PHASE2
-
DHA and Vitamin D in Children With Biopsy-proven NAFLD
NCT02098317 ·Status: COMPLETED ·Phase: PHASE3
-
Treatment of Nonalcoholic Fatty Liver Disease in Children (TONIC)
NCT00063635 ·Status: COMPLETED ·Phase: PHASE3